First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study.
about
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategiesResection versus radiosurgery for patients with brain metastases.Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors.Current management of metastatic brain diseaseCurrent approaches to the treatment of metastatic brain tumours.Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors.Chemotherapy for the treatment of metastatic brain tumors.Chemotherapy and targeted molecular therapies for brain metastases.Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases.Bevacizumab, pemetrexed and carboplatin in first-line treatment of non-small cell lung cancer patients: Focus on patients with brain metastases.Are immune checkpoint blockade monoclonal antibodies active against CNS metastases from NSCLC?-current evidence and future perspectives.Brain metastases: a medical neuro-oncology perspective.Systemic treatment of non-small cell lung cancer brain metastasesCombining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?EGF receptor tyrosine kinase inhibitors in the treatment of brain metastases from non-small-cell lung cancer.Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.Bone marrow-derived stem cell therapy for metastatic brain cancers.Systemic therapy of brain metastases.Systemic therapies in the treatment of non-small-cell lung cancer brain metastases.Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy.Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future.Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer.State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer.Novel Gemcitabine Conjugated Albumin Nanoparticles: a Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment.Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib.Cauda equina syndrome secondary to leptomeningeal metastases from recurrent primary peritoneal carcinoma.Chemotherapy in brain metastases of lung and breast cancer
P2860
Q24568071-222632D1-82A1-4B4D-9BF8-0F1479AD1396Q31097790-E26D5A61-15B7-4207-8EC1-F3DC414EEA9DQ33386298-0F82C9F8-D601-4A6A-B97D-4CD9BED1FB27Q33387996-1C3A0EC7-BD33-4570-AAB9-00AA686BED2CQ33475484-FAC6487A-209A-4EE1-914E-818D1FE00484Q33696559-E1AA5923-39EC-4CD5-99D8-E74B7EDDBF11Q34872345-C7BCEEF2-E246-4FC7-8CB7-E2BF7734B57DQ34969177-22DB1DC1-DDF8-4004-B520-8BE1260D5CABQ36641504-CBA31267-7FDD-4112-9089-FAB242F343FBQ37056891-D65C0E22-E978-4EC1-8F24-B730BB620330Q37581974-9EE2A502-99D7-486D-B42C-0C921DBC28A9Q37584395-3E33C3BB-3B7E-4F81-B5DD-41C2A2F92A83Q37724219-F5405121-73CA-4D62-B0B4-8CC7647B65EBQ37727648-B8F9DBBE-2F9B-4F50-9575-543DA4EFC182Q37870216-F37D4701-BC72-4760-8588-82AAB07E3B97Q38068204-4A514F18-0137-4DC8-8ECA-50185B78C92AQ38233149-B00A60C2-B548-4C6C-BD0E-A4AFDC0C71B9Q38259683-55AA79A8-5D56-4131-A21E-DE9B218D9AF9Q38285931-600A49B6-6086-40C5-8047-DB5262AD5B1EQ38738053-CBC0DEC2-3391-46F4-A845-863CF2EDD06DQ38763104-B9D14DB6-D2D2-449C-8AF5-C812E2C58037Q38763111-7016CE0F-F61A-49CC-9162-4D50835EECC2Q38985337-10E02B54-3711-4FD4-B409-D73463615011Q38985340-6A23BA54-9ECB-479C-AF77-BF42356F9F66Q48696930-6218D67D-B857-4BB0-9A6F-58EF166892B3Q51461588-65113DCE-4773-45A4-B474-0354C6D913C5Q52668295-65F7C121-CF22-4CEC-AAD0-BCDAA3103ECEQ58297721-4955251A-CC25-4F1E-BE04-9AFD6CF67095
P2860
First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
First-line chemotherapy with v ...... lung cancer: a phase II study.
@en
First-line chemotherapy with v ...... lung cancer: a phase II study.
@nl
type
label
First-line chemotherapy with v ...... lung cancer: a phase II study.
@en
First-line chemotherapy with v ...... lung cancer: a phase II study.
@nl
prefLabel
First-line chemotherapy with v ...... lung cancer: a phase II study.
@en
First-line chemotherapy with v ...... lung cancer: a phase II study.
@nl
P2093
P2860
P356
P1433
P1476
First-line chemotherapy with v ...... lung cancer: a phase II study
@en
P2093
Antonio Bernardo
Giovanni Bernardo
Giuseppe Brunetti
Ivona Jedrychowska
Maria Rosa Strada
Quinto Cuzzoni
Umberto Pozzi
P2860
P304
P356
10.1081/CNV-120001173
P577
2002-01-01T00:00:00Z